IP Library Granted Patent US 8,524,272
Granted Patent B2
US 8,524,272 · App. 10/641,654 · Granted Sep 3, 2013

Transdermal patch incorporating active agent migration barrier layer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,272
App. No.
10/641,654
Granted
Sep 3, 2013
Kind
B2
Abstract

Devices for administration of one or more active agents to the skin or mucosa of a host are formed in the nature of a double-disk patch. One outer layer functions as the primary adhesive layer for adhering the patch to the host. The other inner layer contains at least one active agent to be administered to the host. The inner layer is bonded to the outer layer through an opening provided in an interposed active agent impermeable release layer. The release layer separates a circumferential portion of the active agent containing inner layer from the outer adhesive layer to inhibit migration of the active agent therebetween.

Claims (16)

1. A storage-stable device for the release of an active agent to the skin or mucosa of a host, said device consisting of:

an outer patch having adhesive properties;

an inner patch comprising an active agent layer containing an active agent and a coextensive active agent impermeable layer supporting the active agent layer, the active agent impermeable layer having a first surface in contact with the active agent layer and a second surface opposing the first surface; and,

a release liner interposed between the inner patch and the outer patch, the release liner releasably adhered to a first adhesive portion of the outer patch and having an opening exposing a second adhesive portion of the outer patch to the inner patch,

wherein, prior to removal of the release liner for application of the device to the skin or mucosa of a host, a portion of the second surface of the active agent impermeable layer is adhered to the second adhesive portion of the outer patch exposed by the opening in the interposed release liner, and a remaining portion of the second surface of the active agent impermeable layer is unadhered to the first or second adhesive portion of the outer patch as a result of the release liner being interposed therebetween prior to the removal of the release liner for the application of the device; and,

the outer patch having a surface area greater than the surface area of the inner patch, such that removal of the release liner for the application of the device adheres the remaining portion of the active agent impermeable layer to the adhesive layer of the outer patch and exposes another adhesive portion of the outer patch extending beyond the periphery of the inner patch for adhering the device to the skin or mucosa of a host; and a second release liner releasably adhered to said inner patch.

2. The device of claim 1 , wherein said release liner comprises an active agent impermeable material.

3. The device of claim 1 , wherein said inner patch comprises pressure-sensitive adhesive material in contact with said active agent layer for adhering said device to the skin or mucosa of a host.

4. The device of claim 3 , wherein said pressure-sensitive adhesive material comprises a layer of active agent permeable adhesive applied overlying said active agent layer of the inner patch for adhering said device to the skin or mucosa of a host.

5. The device of claim 1 , wherein at least one portion of said outer patch includes an active agent to be administered to the skin or mucosa of a host.

6. The device of claim 1 , wherein said active agent is an analgesic.

7. A storage-stable device for the release of an active agent to the skin or mucosa of a host, the device consisting of:

an outer patch including a backing layer and an adhesive layer supported on the backing layer;

a release liner coextensively and releasably adhered to the adhesive layer of the outer patch, the release liner having an opening exposing therethrough a portion of the adhesive layer;

an inner patch comprising an active agent impermeable layer and an active agent layer containing an active agent supported on the active agent impermeable layer, the active agent impermeable layer having a first portion adhered to the exposed portion of the adhesive layer through the opening in the release liner and a remaining portion of the active agent impermeable layer being separated from the adhesive layer of the outer patch by the release liner interposed between the active agent impermeable layer and the adhesive layer, whereby the first portion of the active agent impermeable layer is adhered to the adhesive layer of the outer patch prior to removal of the release liner for application of the device to the skin or mucosa of the host, and the remaining portion of the active agent impermeable layer is unadhered to the adhesive layer of the outer patch prior to the removal of the release liner for application of the device;

the inner patch having a surface area smaller than the surface area of the outer patch, wherein removal of the release liner adheres the remaining portion of the active agent impermeable layer to the adhesive layer of the outer patch and exposes a peripheral portion of the adhesive layer of the outer patch for adhering the device to the skin or mucosa of the host with the active agent layer in contact with the skin or mucosa of the host for administration of the active agent.

Assignments (5)
PATENT RELEASE Recorded Dec 10, 2012
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: DEY PHARMA L.P. (F/K/A DEY, L.P.); MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.; SOMERSET PHARMACEUTICALS, INC.; MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.); MYLAN INC.
Reel/Frame 029440/0967 →
SECURITY AGREEMENT Recorded Nov 21, 2011
From: MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.; MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.); SOMERSET PHARMACEUTICALS, INC.; DEY PHARMA, L.P. (F/K/A DEY L.P.)
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027270/0799 →
RELEASE OF SECURITY INTEREST Recorded Nov 18, 2011
From: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: MYLAN TECHNOLOGIES, INC.; DEY, INC. (F/K/A DEY LABORATORIES, INC.); MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN PHARMACEUTICALS, INC.; DEY PHARMA, L.P. (F/K/A DEY L.P.); MYLAN INSTITUTION INC. (F/K/A UDL LABORATORIES, INC.); MYLAN INC. (F/K/A MYLAN LABORATORIES INC.)
Reel/Frame 027261/0928 →
SECURITY AGREEMENT Recorded Oct 24, 2007
From: MYLAN LABORATORIES INC.; DEY, L.P.; DEY, INC.; MYLAN PHARMACEUTICALS, INC.; MYLAN TECHNOLOGIES, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; UDL LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 020004/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2003
From: MILLER, KENNETH J. II
To: MYLAN TECHNOLOGIES, INC.
Reel/Frame 014416/0237 →